Thus, understanding the molecular mechanisms that cause radio-resistance in cancers may be useful in improving adjuvant treatments for enhancing the efficacy of radiotherapy
An in vivo experiment based on the acute HH mouse model has confirmed that prophylactic administration of tetrahydrocurcumin can alleviate acute HH-induced brain edema, reduce the levels of inflammatory factors IL-1 and TNF-, increase SOD activity to enhance hypoxia resistance, and inhibit the NF-B/VEGF/MMP-9 pathway to reduce HH-induced brain edema and inflammation, thereby exerting neuroprotective effects (Pan et al., 2020)
Researchers may only use this compound in lab studies
Dilutions WB: 1:500-1:2,000, IHC: 1:50-1:200 Reactivity Human, Mouse, Rat Immunogen Recombinant fusion protein containing a sequence corresponding to amino acids 100-180 of human GPX2 (NP_002074.2)
In addition, continued follow-up with this patient showed that even after 12 months, the patient retained clinical and endoscopic remission of UC, demonstrating an excellent therapeutic outcome